Laurion Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
+1,808
| New | +$396K | 0.01% | 153 |
|
|
2024
Q3 | – | Sell |
-26,937
| Closed | -$8.87M | – | 481 |
|
|
2024
Q2 | $8.87M | Sell |
26,937
-1,097
| -4% | -$361K | 0.11% | 53 |
|
|
2024
Q1 | $11.1M | Buy |
+28,034
| New | +$11.1M | 0.09% | 81 |
|
|
2020
Q4 | – | Sell |
-18,222
| Closed | -$5.01M | – | 744 |
|
|
2020
Q3 | $5.01M | Buy |
18,222
+2,355
| +15% | +$647K | 0.06% | 91 |
|
|
2020
Q2 | $3.61M | Buy |
+15,867
| New | +$3.61M | 0.04% | 90 |
|
|
2019
Q4 | – | Sell |
-15,800
| Closed | -$2.24M | – | 862 |
|
|
2019
Q3 | $2.24M | Buy |
+15,800
| New | +$2.24M | 0.02% | 156 |
|
|
2017
Q2 | – | Sell |
-4,060
| Closed | -$331K | – | 1372 |
|
|
2017
Q1 | $331K | Buy |
+4,060
| New | +$331K | ﹤0.01% | 609 |
|
|
2016
Q4 | – | Sell |
-3,032
| Closed | -$226K | – | 890 |
|
|
2016
Q3 | $226K | Sell |
3,032
-149,968
| -98% | -$11.2M | ﹤0.01% | 401 |
|
|
2016
Q2 | $11.6M | Buy |
+153,000
| New | +$11.6M | 0.18% | 32 |
|
|
2016
Q1 | – | Sell |
-6,100
| Closed | -$367K | – | 849 |
|
|
2015
Q4 | $367K | Buy |
+6,100
| New | +$367K | ﹤0.01% | 242 |
|